“
TL;DR
This narrative review summarizes how growth factors like EGF and VEGF promote angiogenesis and tumor progression in lung cancer.
Cancers · 15 authors, 5 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review summarizes how growth factors like EGF and VEGF promote angiogenesis and tumor progression in lung cancer.
This narrative review article synthesizes literature on the role of growth factors, particularly the EGF and VEGF families, in promoting angiogenesis within lung cancer. The authors describe how angiogenesis stimulates tumor growth, invasion, and metastasis. The review discusses therapeutic strategies that inhibit these growth factors or their downstream signaling pathways, both as monotherapy and combination therapy. Central results from the reviewed literature indicate that anti-angiogenic treatments show encouraging efficacy. However, the authors caution that these therapies carry a higher risk of toxicity, necessitating personalized patient follow-up. Its implications are for informing future research and clinical discussion on therapeutic strategies for lung cancer patients.